Used as tool in cytological research and in characterization of polymerization properties of actin.
Product Details
| Formula: | C29H39NO5 |
| |
| MW: | 481.6 |
| |
| Source: | Semisynthetic. Derived from cytochalasin B (Prod. No. BML-T108), which was isolated from Drechslera dematoidea. |
| |
| CAS: | 39156-67-7 |
| |
| MI: | 14: 2790 |
| |
| Purity: | ≥98% (HPLC, TLC) |
| |
| Appearance: | White solid. |
| |
| Solubility: | Soluble in or acetone, DMSO or 100% ethanol. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Protect from light. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Complex regulation of human neutrophil activation by actin filaments: dihydrocytochalasin B and botulinum C2 toxin uncover the existence of multiple cation entry pathways: K. Wenzel-Seifert, et al.; J. Leukoc. Biol.
61, 703 (1997),
Abstract;
Dihydrocytochalasin B enhances transforming growth factor-beta-induced reexpression of the differentiated chondrocyte phenotype without stimulation of collagen synthesis: P.D. Benya & S.R. Padilla; Exp. Cell Res.
204, 268 (1993),
Abstract;
Microfilament modification by dihydrocytochalasin B causes retinoic acid-modulated chondrocytes to reexpress the differentiated collagen phenotype without a change in shape: P.D. Benya, et al.; J. Cell Biol.
106, 161 (1988),
Abstract;
Dihydrocytochalasin B. Biological effects and binding to 3T3 cells: S.J. Atlas & S. Lin; J. Cell. Biol.
76, 360 (1978),
Abstract;
Related Products
